{"gao_id": "GAO-24-106288", "published": "2023-11-30T12:00:00Z", "released": "2023-11-30T07:00:00Z", "summary": "Patients experiencing kidney failure rely on dialysis and other treatments for life-sustaining care. The Centers for Medicare & Medicaid Services pays dialysis organizations for the care with a bundled payment that includes dialysis, certain drugs, and other costs like lab work. Currently \"phosphate binders\"\u2014drugs commonly used among this population\u2014aren't part of the bundle. CMS plans to add them in 2025, which may require dialysis organizations...", "title": "End-Stage Renal Disease: CMS Plans for Including Phosphate Binders in the Bundled Payment", "topics": ["Medicare plans", "Prescription drugs", "Fee-for-service", "Pharmacy", "Medicare", "Urologic diseases", "Beneficiaries", "Quality of care", "Health Care", "Drugs", "Dialysis"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-24-106288", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/d24106288HIGH.pdf"}, {"title": "Full Report (30 pages)", "url": "https://www.gao.gov/assets/d24106288.pdf"}]}